Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Inhalation is a common condition in patients with impaired their awareness requiring protection of the upper airway by endotracheal intubation. This inhalation may lead to chemical pneumonitis and/or bacterial pneumonia. Only the latter requires the administration of antibiotics. Patients developing such a bacterial pneumonia, has a mortality, duration of mechanical ventilation and length of ICU stay increased. However, the proportion of patients with such bacterial pneumonia, bacterial ecology and morbidity that are little known.
The aim of this study is to determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Coma patients in ICU under mechanical ventilation |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation | Participants will be followed for the duration of ICU stay, an expected average of 4 days | ICU Discharge |
| Measure | Description | Time Frame |
|---|---|---|
| Quantify the use of antibiotics during the ICU stay for patients admitted to the ICU for coma and treated with mechanical ventilation | Participants will be followed for the duration of ICU stay, an expected average of 4 days | ICU Discharge |
| Description of the bacterial flora identified in respiratory specimens. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients hospitalized in ICU for coma (define by Glasgow score < 8) and under mechanical ventilation. Suspicion of bacterial inhalation pneumonia will be confirme by a protected distal sampling during a flexible bronchoscopy.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean Baptiste Lascarrou, MD | CHD Vendee | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHD Vendee | La Roche-sur-Yon | 85000 | France |
Not provided
| ID | Term |
|---|---|
| D011015 | Pneumonia, Aspiration |
| D003128 | Coma |
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Participants will be followed for the duration of ICU stay, an expected average of 4 days |
| ICU Discharge |
| Identification of predictive factors for development of bacterial pneumonia | Participants will be followed for the duration of ICU stay, an expected average of 4 days | ICU Discharge |
| D012140 |
| Respiratory Tract Diseases |
| D014474 | Unconsciousness |
| D003244 | Consciousness Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |